Vanda Pharmaceuticals Inc. (VNDA)

NASDAQ: VNDA · IEX Real-Time Price · USD

5.27

-0.31 (-5.56%)

At close: Jul 2, 2024, 4:00 PM

5.33

+0.06 (1.14%)

After-hours: Jul 2, 2024, 7:56 PM EDT

Vanda Pharmaceuticals Market Cap

Vanda Pharmaceuticals has a market cap or net worth of $306.71 million as of July 2, 2024. Its market cap has decreased by -18.10% in one year.

Market Cap

306.71M

Enterprise Value

-80.92M

1-Year Change

-18.10%

Ranking

#3251

Market Cap Chart

Since April 12, 2006, Vanda Pharmaceuticals's market cap has increased from $209.50M to $306.71M, an increase of 46.40%. That is a compound annual growth rate of 2.11%.

Market Cap History

Date	Market Cap	% Change
Jul 1, 2024	324.70M	33.73%
Dec 29, 2023	242.80M	-41.94%
Dec 30, 2022	418.20M	-52.16%
Dec 31, 2021	874.10M	21.64%
Dec 31, 2020	718.60M	-17.90%
Dec 31, 2019	875.30M	-36.13%
Dec 31, 2018	1.37B	100.69%
Dec 29, 2017	682.90M	-2.57%
Dec 30, 2016	700.90M	75.84%
Dec 31, 2015	398.60M	-17.90%
Dec 31, 2014	485.50M	17.87%
Dec 31, 2013	411.90M	294.54%
Dec 31, 2012	104.40M	-21.97%
Dec 30, 2011	133.80M	-49.57%
Dec 31, 2010	265.30M	-13.30%
Dec 31, 2009	306.00M	2,200.75%
Dec 31, 2008	13.30M	-92.75%
Dec 31, 2007	183.40M	-66.04%
Dec 29, 2006	540.00M	157.76%

View and export this data all the way back to 2006. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
AxoGen	336.96M
Kyverna Therapeutics	336.73M
C4 Therapeutics	333.71M
Pacific Biosciences of California	326.83M
Tourmaline Bio	326.74M
Foghorn Therapeutics	323.12M
Xeris Biopharma Holdings	321.72M
Cerus	318.01M

Market Cap Rankings